Grbčić, P.; Fučkar Čupić, D.; Gamberi, T.; Kraljević Pavelić, S.; Sedić, M.
Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib. Int. J. Mol. Sci. 2021, 22, 6174.
https://doi.org/10.3390/ijms22126174
AMA Style
Grbčić P, Fučkar Čupić D, Gamberi T, Kraljević Pavelić S, Sedić M.
Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib. International Journal of Molecular Sciences. 2021; 22(12):6174.
https://doi.org/10.3390/ijms22126174
Chicago/Turabian Style
Grbčić, Petra, Dora Fučkar Čupić, Tania Gamberi, Sandra Kraljević Pavelić, and Mirela Sedić.
2021. "Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib" International Journal of Molecular Sciences 22, no. 12: 6174.
https://doi.org/10.3390/ijms22126174
APA Style
Grbčić, P., Fučkar Čupić, D., Gamberi, T., Kraljević Pavelić, S., & Sedić, M.
(2021). Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib. International Journal of Molecular Sciences, 22(12), 6174.
https://doi.org/10.3390/ijms22126174
